Citigroup’s Principal Exchange-Traded Funds Principal Healthcare Innovators ETF BTEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-250
Closed -$14K 6135
2021
Q3
$14K Sell
250
-2,050
-89% -$116K ﹤0.01% 5390
2021
Q2
$140K Buy
2,300
+250
+12% +$14.3K ﹤0.01% 4394
2021
Q1
$118K Buy
2,050
+500
+32% +$31.3K ﹤0.01% 4285
2020
Q4
$91K Buy
+1,550
New +$83.6K ﹤0.01% 5614
2018
Q4
Sell
-151
Closed -$6K 7872
2018
Q3
$6K Buy
+151
New +$5.49K ﹤0.01% 7470

Other funds holding BTEC

Citigroup's BTEC Position: Q4 2021 in Review

Citigroup sold out of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) in Q4 2021, closing a stake of 250 shares — an estimated $14K sold.

Citigroup first reported a position in BTEC in Q3 2018 and held it in 5 quarters. The position peaked at $140K in Q2 2021. 33 funds tracked by Wall St. Rank hold BTEC as of Q4 2021.

  • Citigroup reported no remaining Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position as of Q4 2021 after selling out during the quarter.
  • Citigroup sold 250 Principal Exchange-Traded Funds Principal Healthcare Innovators ETF shares in Q4 2021, an estimated $14K.
  • Citigroup first reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in Q3 2018 and held it in 5 quarters.
  • Citigroup's Principal Exchange-Traded Funds Principal Healthcare Innovators ETF position peaked at $140K in Q2 2021.
  • 33 funds tracked by Wall St. Rank held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF as of Q4 2021.

Based on Citigroup's 13F filing for Q4 2021, filed 10 Feb 2022.